Provided is a kit comprising a vaccine to the influenza virus. The vaccine can be an immunogenic composition that comprises an inactivated influenza virus. The immunogenic compositions elicits can include subtypes A and/or type B of the influenza virus. A container, such as a single dose pre-filled syringe of the vaccine is placed inside of the kit. Another component of the kit can include a CSR (Central Supply Room) wrap. Another component of the kit can include sterile gloves. Another component of the kit can include a bandage. Another component of the kit can include a disinfectant for topical application, such as an alcohol pad. Another component of the kit can include an instruction sheet.
